Operating income increased 39.4%
Operating income changed +39.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +39.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Research & development changed -83.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed -74.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current assets changed -54.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Net income changed +23.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.